keyword
MENU ▼
Read by QxMD icon Read
search

industry funding

keyword
https://www.readbyqxmd.com/read/28645203/neurosurgical-randomized-controlled-trials-distance-travelled
#1
Tej D Azad, Anand Veeravagu, Vaishali Mittal, Rogelio Esparza, Eli Johnson, John P A Ioannidis, Gerald A Grant
BACKGROUND: The evidence base for many neurosurgical procedures has been limited. We performed a comprehensive and systematic analysis of study design, quality of reporting, and trial results of neurosurgical randomized controlled trials (RCTs). OBJECTIVE: To systematically assess the design and quality characteristics of neurosurgical RCTs. METHODS: From January 1961 to June 2016, RCTs with >5 patients assessing any 1 neurosurgical procedure against another procedure, nonsurgical treatment, or no treatment were retrieved from MEDLINE, Scopus, and Cochrane Library...
June 21, 2017: Neurosurgery
https://www.readbyqxmd.com/read/28639415/anti-vascular-endothelial-growth-factor-for-diabetic-macular-oedema-a-network-meta-analysis
#2
REVIEW
Gianni Virgili, Mariacristina Parravano, Jennifer R Evans, Iris Gordon, Ersilia Lucenteforte
BACKGROUND: Diabetic macular oedema (DMO) is a common complication of diabetic retinopathy. Antiangiogenic therapy with anti-vascular endothelial growth factor (anti-VEGF) modalities can reduce oedema and thereby improve vision and prevent further visual loss. These drugs have replaced laser photocoagulation as the standard of care for people with DMO. OBJECTIVES: The 2014 update of this review found high-quality evidence of benefit with antiangiogenic therapy with anti-VEGF modalities, compared to laser photocoagulation, for the treatment of DMO...
June 22, 2017: Cochrane Database of Systematic Reviews
https://www.readbyqxmd.com/read/28637441/impact-of-tobacco-industry-and-other-corporations-in-the-defeat-of-the-1994-clinton-health-care-plan
#3
Michael Givel
BACKGROUND: The primary reason cited by many scholars for the defeat of the Clinton Administration's 1994 health care reform bill has long been identified as Health Insurance Association of America and National Federation of Independent Businesses opposition to the bill. Given this predominant consensus combined with sizeable proposed funding for the bill by a large tobacco product tax, this manuscript examined what the tobacco industry's role was in whole or part in defeating the Clinton health care bill...
June 21, 2017: BMC Public Health
https://www.readbyqxmd.com/read/28636762/european-diabetes-research-and-its-funding-2002-2013
#4
M Begum, G Lewison, S Sommariva, O Ciani, R Tarricone, R Sullivan
AIM: This study examined the outputs of research papers in diabetes from 31 European countries between 2002 and 2013, and their funding. METHODS: Diabetes research papers in the Web of Science were identified by means of a filter based on journals and title words. For 2009-2013 papers, the funders were coded to show their sector and nationality. RESULTS: Europe published 40 547 diabetes papers in the 12 years between 2002 and 2013. Denmark, Sweden and Finland published the most relative to their wealth, but the UK published the most absolutely despite an apparently low burden (as measured by disability-adjusted life years)...
June 21, 2017: Diabetic Medicine: a Journal of the British Diabetic Association
https://www.readbyqxmd.com/read/28636448/ebola-virus-training-a-needs-assessment-and-gap-analysis
#5
Kevin Yeskey, Joseph Hughes, Betsy Galluzzo, Nina Jaitly, James Remington, Deborah Weinstock, Joy Lee Pearson, Jonathan D Rosen
In response to the 2014 Ebola virus disease outbreak, the Worker Training Program embarked on an assessment of existing training for those at risk for exposure to the virus. Searches of the recent peer-reviewed literature were conducted for descriptions of relevant training. Federal guidance issued during 2015 was also reviewed. Four stakeholder meetings were conducted with representatives from health care, academia, private industry, and public health to discuss issues associated with ongoing training. Our results revealed few articles about training that provided sufficient detail to serve as models...
May 2017: Health Security
https://www.readbyqxmd.com/read/28633984/herbal-medicinal-products-in-pregnancy-which-data-are-available
#6
REVIEW
Jacqueline Wiesner, Werner Knöss
This review aims to highlight recent approaches concerning usage of (traditional) herbal medicinal products in pregnancy and to discuss appropriate strategies to handle limited information. Therefore, published monographs of the Committee on Herbal Medicinal products (HMPC) and selected publicly funded webpages, medicinal handbooks, publications and industry and health care organisations webpages were evaluated. While within the monographs of the HMPC a rather conservative approach could be found (mainly because of lacking nonclinical and/or clinical studies), all other sources display a wide variety of information or assessments, thereby often giving contradictory recommendations...
June 17, 2017: Reproductive Toxicology
https://www.readbyqxmd.com/read/28626425/lemons-or-squeezed-for-resources-information-symmetry-and-asymmetric-resources-in-biotechnology
#7
Arthur Neuberger, Nektarios Oraiopoulos, Donald L Drakeman
Thousands of biotech companies are developing promising products, but have insufficient resources to complete the clinical testing process, while large, well-funded companies have increasingly focused on the need to access external innovation. As a result, licensing deals are an essential and growing part of this industry. Yet, casting a shadow over the licensing market is the classic Lemons Problem: Does asymmetrical information put licensees at a severe disadvantage, leading to a market dominated by inferior opportunities, with the best products retained for internal development? Our analysis of clinical stage products developed over three decades shows that there is no Lemons Problem...
2017: Frontiers in Pharmacology
https://www.readbyqxmd.com/read/28622947/discontinuation-and-non-publication-of-clinical-trials-in-cardiovascular-medicine
#8
Alistair J Roddick, Fiona T S Chan, James D Stefaniak, Sean L Zheng
BACKGROUND: Appropriate dissemination of clinical data is crucial for minimising bias. Despite this, high rates of study discontinuation and non-publication have been reported among clinical trials. Cardiovascular medicine receives a substantial proportion of academic funding; however, predictors of non-publication among cardiovascular trials are not well-established. METHODS: The National Clinical Trials database was searched for cardiovascular trials completed between January 2010 and January 2014...
June 7, 2017: International Journal of Cardiology
https://www.readbyqxmd.com/read/28620039/csbb-synthetic-biology-research-at-newcastle-university
#9
EDITORIAL
Angel Goñi-Moreno, Anil Wipat, Natalio Krasnogor
The Centre for Synthetic Biology and the Bioeconomy (CSBB) brings together a far-reaching multidisciplinary community across all Newcastle University's faculties - Medical Sciences, Science, Agriculture and Engineering, and Humanities, Arts and Social Sciences. The CSBB focuses on many different areas of Synthetic Biology, including bioprocessing, computational design and in vivo computation, as well as improving understanding of basic molecular machinery. Such breadth is supported by major national and international research funding, a range of industrial partners in the North East of England and beyond, as well as a large number of doctoral and post-doctoral researchers...
June 15, 2017: Biochemical Society Transactions
https://www.readbyqxmd.com/read/28617238/public-health-policy-in-support-of-insurance-coverage-for-smoking-cessation-treatments
#10
Robert Schwartz, Farzana Haji, Alexey Babayan, Christopher Longo, Roberta Ferrence
Insurance coverage for evidence-based smoking cessation treatments (SCTs) promotes uptake and reduces smoking rates. Published studies in this area are based in the US where employers are the primary source of health insurance. In Ontario, Canada, publicly funded healthcare does not cover SCTs, but it can be supplemented with employer-sponsored benefit plans. This study explores factors affecting the inclusion/exclusion of smoking cessation (SC) benefits. In total, 17 interviews were conducted with eight employers (auto, retail, banking, municipal and university industries), four health insurers, two government representatives and three advisors/consultants...
May 2017: Healthcare Policy, Politiques de Santé
https://www.readbyqxmd.com/read/28614452/-profile-of-clinical-trials-enrolling-brazilian-children
#11
Jean Mendes de Lucena Vieira, Elisangela da Costa Lima, Marcelo Gerardin Poirot Land, Miriam Ventura, Helena Lutescia Luna Coelho
This study aimed to characterize the clinical trials with medicines enrolling Brazilian children and adolescents, registered in the databases of Clinical Trials and the Brazilian Clinical Trials Network (ReBEC) from 1994 to 2014. Only 462 clinical trials enrolled Brazilian children and adolescents. There was an increase in registrations beginning in 2003, with an important drop in 2011. Among these trials, 35.5% were hosted in Brazil. The international clinical trials were mostly conducted by North American companies...
June 12, 2017: Cadernos de Saúde Pública
https://www.readbyqxmd.com/read/28608642/australia-and-germany-large-distance-close-collaborations
#12
EDITORIAL
Christopher Barner-Kowollik
"… Both Australia and Germany have long traditions in the chemical sciences, however there is considerable scope to expand collaborations between the two chemical research communities. This can be achieved by collaborative funding opportunities, closing the gap between fundamental research and industrial applications, and targeted interactive symposia …" Read more in the Editorial by Christopher Barner-Kollowik.
June 13, 2017: Angewandte Chemie
https://www.readbyqxmd.com/read/28605615/cancer-drugs-an-international-comparison-of-postlicensing-price-inflation
#13
Philip Savage, Sarah Mahmoud, Yogin Patel, Hagop Kantarjian
PURPOSE: The cost of cancer drugs forms a rising proportion of health care budgets worldwide. A number of studies have examined international comparisons of initial cost, but there is little work on postlicensing price increases. To examine this, we compared cancer drug prices at initial sale and subsequent price inflation in the United States and United Kingdom and also reviewed relevant price control mechanisms. METHODS: The 10 top-selling cancer drugs were selected, and their prices at initial launch and in 2015 were compared...
June 2017: Journal of Oncology Practice
https://www.readbyqxmd.com/read/28595992/-food-industry-funding-and-epidemiologic-research-in-public-health-nutrition
#14
Eva María Navarrete-Muñoz, Adonina Tardón, Dora Romaguera, Miguel Ángel Martínez-González, Jesús Vioque
The interests of the food industry to fund nutrition and health research are not limited to promoting scientific advances. Recently, several systematic reviews conducted about the effect of sugar-sweetened beverages and health outcomes have shown some biased conclusions in studies that acknowledge industry sponsorship. In this context, the Nutrition Working Group of the Spanish Epidemiology Society presented a scientific session entitled Food industry and epidemiologic research at its annual meeting. In a round table, four experts in nutrition research presented their points of view about whether the food industry should fund nutrition-related research and the related potential conflicts of interest of the food industry...
June 5, 2017: Gaceta Sanitaria
https://www.readbyqxmd.com/read/28595804/techno-economic-feasibility-of-waste-biorefinery-using-slaughtering-waste-streams-as-starting-material-for-biopolyester-production
#15
Khurram Shahzad, Michael Narodoslawsky, Muhammad Sagir, Nadeem Ali, Shahid Ali, Muhammad Imtiaz Rashid, Iqbal Mohammad Ibrahim Ismail, Martin Koller
The utilization of industrial waste streams as input materials for bio-mediated production processes constitutes a current R&D objective not only to reduce process costs at the input side but in parallel, to minimize hazardous environmental emissions. In this context, the EU-funded project ANIMPOL elaborated a process for the production of polyhydroxyalkanoate (PHA) biopolymers starting from diverse waste streams of the animal processing industry. This article provides a detailed economic analysis of PHA production from this waste biorefinery concept, encompassing the utilization of low-quality biodiesel, offal material and meat and bone meal (MBM)...
June 5, 2017: Waste Management
https://www.readbyqxmd.com/read/28592574/dyspnoea-12-a-translation-and-linguistic-validation-study-in-a-swedish-setting
#16
Josefin Sundh, Magnus Ekström
BACKGROUND: Dyspnoea consists of multiple dimensions including the intensity, unpleasantness, sensory qualities and emotional responses which may differ between patient groups, settings and in relation to treatment. The Dyspnoea-12 is a validated and convenient instrument for multidimensional measurement in English. We aimed to take forward a Swedish version of the Dyspnoea-12. METHODS: The linguistic validation of the Dyspnoea-12 was performed (Mapi Language Services, Lyon, France)...
June 6, 2017: BMJ Open
https://www.readbyqxmd.com/read/28589444/reflections-on-the-future-of-pharmaceutical-public-private-partnerships-from-input-to-impact
#17
REVIEW
Remco L A de Vrueh, Daan J A Crommelin
Public Private Partnerships (PPPs) are multiple stakeholder partnerships designed to improve research efficacy. We focus on PPPs in the biomedical/pharmaceutical field, which emerged as a logical result of the open innovation model. Originally, a typical PPP was based on an academic and an industrial pillar, with governmental or other third party funding as an incentive. Over time, other players joined in, often health foundations, patient organizations, and regulatory scientists. This review discusses reasons for initiating a PPP, focusing on precompetitive research...
June 6, 2017: Pharmaceutical Research
https://www.readbyqxmd.com/read/28587885/destination-bioeconomy-the-path-towards-a-smarter-more-sustainable-future
#18
REVIEW
Joanna Dupont-Inglis, Agnes Borg
Five years following the publication of the EU Bioeconomy Strategy, this article discusses the state of play of the bioeconomy in Europe. Placing specific focus on Industrial Biotech, it outlines ten pragmatic recommendations from BIO-TIC [BIO-TIC, A roadmap to a thriving industrial biotechnology sector in Europe, 2015], an EU FP7 funded project completed in 2015 and coordinated by EuropaBio, comprehensively examining the hurdles to the development of a bioeconomy in Europe, enabled by industrial biotech. These include improving opportunities for feedstock producers within the bioeconomy; investigating the scope for using novel biomass; developing a workforce which can maintain Europe's competitiveness in industrial biotechnology; introducing a long-term, stable and transparent policy and incentive framework to promote the bioeconomy; improving public perception and awareness of industrial biotechnology and bio-based products; identifying, leveraging and building upon EU capabilities for pilot and demonstration facilities; promoting the use of co-products from processing; improving the bioconversion and downstream processing steps; improving access to financing for large-scale biorefinery projects; developing stronger relationships between conventional and non-conventional players...
June 3, 2017: New Biotechnology
https://www.readbyqxmd.com/read/28583869/total-disc-replacement-versus-multidisciplinary-rehabilitation-in-patients-with-chronic-low-back-pain-and-degenerative-discs-eight-year-follow-up-of-a-randomized-controlled-multicenter-trial
#19
Håvard Furunes, Kjersti Storheim, Jens Ivar Brox, Lars Gunnar Johnsen, Jan Sture Skouen, Eric Franssen, Tore K Solberg, Leiv Sandvik, Christian Hellum
BACKGROUND CONTEXT: Lumbar total disc replacement is a treatment option for selected patients with chronic low back pain that is non-responsive to conservative treatment. The long-term results of disc replacement compared to multidisciplinary rehabilitation have not been reported previously. PURPOSE: We aimed to assess the long-term relative efficacy of lumbar total disc replacement compared to multidisciplinary rehabilitation. DESIGN: We undertook a multicenter randomized controlled trial at five university hospitals in Norway...
June 2, 2017: Spine Journal: Official Journal of the North American Spine Society
https://www.readbyqxmd.com/read/28582996/barriers-and-opportunities-to-implementation-of-sustainable-e-health-programmes-in-uganda-a-literature-review
#20
Vincent M Kiberu, Maurice Mars, Richard E Scott
BACKGROUND: Most developing countries, including Uganda, have embraced the use of e-Health and m-Health applications as a means to improve primary healthcare delivery and public health for their populace. In Uganda, the growth in the information and communications technology industry has benefited the rural communities and also created opportunities for new innovations, and their application into healthcare has reported positive results, especially in the areas of disease control and prevention through disease surveillance...
May 29, 2017: African Journal of Primary Health Care & Family Medicine
keyword
keyword
118760
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"